WSB-31403-68131
5 vaccinations
4 coded responses
54 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 550 / MN
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-23
-
2020-12-24
Survey response — days 1–6 daily, dose 1MedDRA: Oral herpes — Feeling: GoodFree text: Cold soreMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
- 2021-01-11
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-20
- 2021-02-25
- 2021-04-15
- 2021-07-16
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: SweatyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-05
- 2021-11-11
- 2021-12-29
- 2022-04-01
-
2022-07-13
Dose 4 — Moderna
- 2022-09-30
-
2022-10-11
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-12
Survey response — days 1–6 daily, dose 5MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Difficulty sleepingMedDRA releases: 2024-11 · check-in free text available
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-10
- 2022-11-15
- 2022-11-22
- 2023-01-10
-
2023-04-11
Survey response — 6 months, dose 5MedDRA: Gestational diabetes — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-07-13 | Moderna | No |
| 5 | 2022-10-11 | Pfizer-BioNTech | Flu |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Cold sore
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Sweaty
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Difficulty sleeping
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Oral herpes | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release